Recently, the search frequency for iGene, known as a biopharmaceutical development company, has surged.


As of 2:31 PM on the 15th, iGene's stock price is 14,050 KRW, up 1.81% from the previous day, with a trading volume of 603,325 shares, which is 33.81% of the 5-day average trading volume.


On March 11, iGene became a market topic with the news, "Expectations for COVID-19 vaccine development... efficacy comparable to Moderna and easier storage."



※Source: AI Investment Assistant AI Racciro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing